Setareh Sharzehi

Setareh Sharzehi

Auto-generated profile, based on publicly available information

Setareh Sharzehi

Knight Cancer Institute Oregon Health & Science University Portland Oregon USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Gastroenterology
Verified
Journal Article
Closed access
MMMatthew T. Moyer
Matthew T. Moyer
SSSetareh Sharzehi
Setareh Sharzehi
AMAbraham Mathew
Abraham Mathew
JLJohn M. Levenick
John M. Levenick
BHBrandy D. Headlee
Brandy D. Headlee
CDCharles E. Dye
Charles E. Dye

14 July 2020 in Endoscopy
Verified
Journal Article
Closed access
PDF file
CMChetan Mittal
Chetan Mittal
DDDavid L Diehl
David L Diehl
PDPeter V. Draganov
Peter V. Draganov
LJLaith H. Jamil
Laith H. Jamil
AKAmmara Khalid
Ammara Khalid
MWMihir S. Wagh
Mihir S. Wagh
Background Flexible endoscopic myotomy has been increasingly performed for Zenker’s diverticulum using various endoscopic techniques and devices. The main aims of this study were to assess practice patterns and compare outcomes of endoscopic myotomy for Zenker’s diverticulum. Methods Procedures performed at 12 tertiary endoscopy centers from 1/2012 to 12/2018 were reviewed. Patients (≥ 18 years) with Zenker’s diverticulum who had dysphagia and/or regurgitation and underwent endoscopic myotomy were included. Outcomes assessed included technical success, clinical success, and adverse events. Results 161 patients were included. Traditional endoscopic septotomy was performed most frequently (137/161, 85.1 %) followed by submucosal dissection of the septum and myotomy (24/161, 14.9 %). The hook knife (43/161, 26.7 %) and needle-knife (33/161, 20.5 %) were used most frequently. Overall, technical and clinical success rates were 98.1 % (158/161) and 78.1 % (96/123), respectively. Adverse events were noted in 13 patients (8.1 %). There was no significant difference in technical and clinical success between traditional septotomy and submucosal dissection groups (97.1 % vs. 95.8 %, P = 0.56 and 75.2 % vs. 90.9 %, P = 0.16, respectively). Clinical success was higher with the hook knife (96.7 %) compared with the needle-knife (76.6 %) and insulated tip knife (47.1 %). Outcomes were similar between centers performing > 20, 11 – 20, and ≤ 10 procedures. Conclusions Flexible endoscopic myotomy is an effective therapy for Zenker’s diverticulum, with a low rate of adverse events. There was no significant difference in outcomes between traditional septotomy and a submucosal dissection approach, or with centers with higher volume, though clinical success was higher with the hook knife.

29 March 2021 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
SJSunil K. Joshi
Sunil K. Joshi
SSSetareh Sharzehi
Setareh Sharzehi
JPJanét Pittsenbarger
Janét Pittsenbarger
DBDaniel Bottomly
Daniel Bottomly
CTCristina E. Tognon
Cristina E. Tognon
ETElie Traer
Elie Traer
Click on the article title to read more.

1 January 2020 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
CAChristopher Febres Aldana
Christopher Febres Aldana
RPRobert Poppiti
Robert Poppiti
JVJohn M Varlotto
John M Varlotto
RVRick Voland
Rick Voland
MZMichael Zaleski
Michael Zaleski
NRNegar Rassaei
Negar Rassaei
Programmed death-ligand 1 (PD-L1) expression is a biomarker for cancer immunotherapy. Diabetes mellitus type-2 is a comorbid disease associated with adverse outcomes in Non-Small Cell Lung Cancer (NSCLC). We aimed to investigate the differences in PD-L1 expression in diabetics. A matched case-control cohort of surgically-resected NSCLC was assembled from an early multicenter study (PMID: 19152440). PD-L1 immunohistochemistry (Clone 22C3) was graded by a tumor positive score (TPS) system (TPS0: no staining; TPS1: <1%; TPS2: 1-49%; TPS3: ≥50%). Variables showing significance at univariate survival analysis were fit in a Cox regression survival model. Diabetics (n=40) and nondiabetics (n=39) showed no differences in age, gender, cancer stage, and follow-up. NSCLCs were more likely PD-L1 positive in diabetics but with tumor positivity <50% (TPS0: 7.5 vs. 20.5%, TPS1: 35 vs. 25.6%, TPS2: 45 vs.23.1%, TPS3: 12.5 vs. 30.8%, respectively; P<0.05). In diabetics, squamous cell carcinomas (SCC) and adenocarcinomas were mainly TPS2 (65% vs. 20%) and TPS1 (50% vs. 26%), respectively. Peritumoral inflammation correlated with TPS (r=0.228), a relationship accentuated in diabetics (r=0.377, P<0.05) but diminished and non-significant in nondiabetics (r=0.136, P≥0.05). This association was stronger in SCC (r=0.424). Diabetes was associated with increased tumor recurrence (HR: 3.08; 95%CI: 1.027-9.23). Diabetes is associated with an increase in peritumoral inflammation, PD-L1 positivity, and recurrence in NSCLC, more pronounced in SCC, suggesting the possibility of metabolic reprogramming and upregulation of PD-L1 by inducible pathways.

1 June 2018 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
PDF file
CMChetan Mittal
Chetan Mittal
Harshit KHaraHarshit KHara
Harshit KHara
SSSetareh Sharzehi
Setareh Sharzehi
AMAbraham Mathew
Abraham Mathew
AKAmmara Khalid
Ammara Khalid
MWMihir S. Wagh
Mihir S. Wagh

1 May 2017 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
PDF file
MMMatthew T. Moyer
Matthew T. Moyer
SSSetareh Sharzehi
Setareh Sharzehi
CDCharles Dye
Charles Dye
TMThomas J. McGarrity
Thomas J. McGarrity
JLJohn M. Levenick
John M. Levenick
BABrooke Ancrile
Brooke Ancrile